Results: GAL-3 was significantly higher in the patient's group 17.98 vs. 10.24 ng/mL; p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Introduction: Elevated galectin-3 GAL-3 levels has been associated with decompensated heart failure HF which is a complex mechanical and neurohormonal syndrome.
📊
Temel Bulgular & Veri:In a group of patients who are referred to the emergency clinic for HF, GAL-3 levels and their association with various clinical and biochemical parameters were determined.
💡
Sonuç & Katkı:Results: GAL-3 was significantly higher in the patient's group 17.98 vs. 10.24 ng/mL; p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Galectin-3 · Heart Failure · RDW
Abstract
Introduction: Elevated galectin-3 GAL-3 levels has been associated with decompensated heart failure HF which is a complex mechanical and neurohormonal syndrome. Many clinical and biochemical factors have been implicated in the pathophysiology of HF. In a group of patients who are referred to the emergency clinic for HF, GAL-3 levels and their association with various clinical and biochemical parameters were determined. GAL-3levels were measured with the VIDAS® automated enzyme-linked fluorescent assay BioMérieux, France . Method: Our study group consists of 70 patients 33 women and 37 men and 25 healthy controls. All 70 patients had at least Class II or higher levels of HF according to NYHA criteria. Results: GAL-3 was significantly higher in the patient's group 17.98 vs. 10.24 ng/mL; p
KAYA, A., ADEMOGLU, E., YİGİT, Z., PURİSA, S., UZUNHASAN, İ. (2016). High GAL-3 may be Associated with Higher Age and Low Levels of Chloride, RDW, and MCHC in Heart Failure. The Ulutas Medical Journal, Cilt: 2 - Sayı: 4, 159–165. https://ajindex.com/articles/844490
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicarefee-for-service program. N Engl J Med. 2009;360:1418-1428. Boer RA, vanVeldhuisen DJ, Gansevoort RT, MullerKobold AC, vanGilst WH, Hillege HL, Bakker SJ,van der Harst P.The fibrosis marker galectin-3 and outcome in the general population. J Intern Med. 2012;272(1):55-64. Peacock F.How galectin-3 changes acute heart failure decision making in the emergency department. Clin Chem Lab Med. 2014; 52(10): 1409–1412.
Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Schroen B, Andrè S, Crijns HJ, Gabius HJ, Maessen J, Pinto YM. Galectin-3 marks activated macrophages in failure- prone hypertrophied hearts and contributes to cardiac dysfunction.Circulation. 2004; 110(19):3121-3128.
Milting H, Ellinghaus P, Seewald M, Cakar H, Bohms B, Kassner A, Körfer R, Klein M, Krahn T, Kruska L, El Bnayosy A, Kramer F. J Heart LungTransplant. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory devices. J Heart Lung Transplant. 2008;27(6):589-596.
Van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF, Martinez A, Crijns HJ, MacRae CA, Menheere PP, Pinto YM. Utility of amino grup-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol. 2006;48(6):1217-24. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168:316-24.
Filipe MD, Meijers WC, Rogiervan der Velde A, de Boer RA. Galectin-3 and heart failure: prognosis, prediction & clinical utility.Clin Chim Acta. 2015;443:48-56.
Zhang Y, Zhang R, An T, Huang Y, Guo X, Yin S, Wang Y, Ji S, Lv R, Zhang J, Maisel A. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure. J Card Fail. 2015;21(1):51-59. McCullough P, de Boer RA, Edelmann F, Lewis CM, Maisel AS.Utilization of galectin-3 in case management across the spectrum of heart failure. Rev Cardiovasc Med. 2014;15(3):197-207.
Zamora E, Lupón J, de Antonio M, Galán A, Domingo M, Urrutia A Troya M, Bayes-Genis A. Renal function largely in